However, another case–control study compared the HP seropositivity prevalence in 466 SLE patients with a matched control group and discovered that SLE patients were less likely to be seropositive (36.5%) for HP in comparison with the healthy controls (42.9%). This evidence concerns the gene HP and systemic lupus erythematosus.